This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Check, E. Panel slated for leniency over study of NIH consulting roles. Nature 429, 230 (2004). https://doi.org/10.1038/429230b
Issue date:
DOI: https://doi.org/10.1038/429230b
This article is cited by
-
Use of NIH funds placed under a spotlight
Nature (2005)
-
Biotech consulting, investing by NIH scientists curbed
Nature Biotechnology (2005)
-
Tough talker quits Congress for bioindustry
Nature (2004)
-
Industry wary of NIH consultancy moratorium
Nature Biotechnology (2004)
-
NIH researchers face blanket consulting ban
Nature (2004)